iOnctura Appoints Industry Veteran Dr. Joanna Horobin as Chair

Geneva, Switzerland, 27 May 2010: iOnctura SA, a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, today announces that it has appointed Dr. Joanna Horobin as non-executive Chair to the iOnctura Board with immediate effect.

Joanna Horobin M.B., Ch.B. is an accomplished drug developer and biotech leader with over 35 years of experience in the pharmaceutical and biotech sector in Europe and the US. Dr. Horobin has held multiple C-suite roles in biotech companies in the USA, most recently as the Chief Medical Officer at Idera Pharmaceuticals Inc. (NASDAQ, IDRA) and was also the CEO of Syndax Pharmaceuticals (NASDAQ, SNDX).

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...